Komori
FUJIFILM Holdings (4901) · FactWorsened

Decline in Profit Before Tax and Net Income Due to Impairment Losses on Equity Securities

First written in FY2020-Q1. 9 of 22 entries say "Worsened", first in FY2020-Q2. Latest entry: FY2025.

22entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2021-Q1 – FY2022-Q3WorsenedFY2022 – FY2023OtherFY2024-Q1 – FY2024WorsenedFY2025-H1 – FY20252019: 220192020: 420202021: 420212022: 420222023: 420232024: 320242025: 12025
Same theme, other companies
Recognition of Valuation Losses on Investment Securities and Impairment LossesA theme 282 companies write about · 285 as a headwind · 0 as a tailwind

FUJIFILM Holdings moved to the "Worse" side of this theme in 2019, 4 years before the typical company in this theme (2023).

The whole theme swung hardest in 2026: 35 of 81 companies on the "Worse" side.

16 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 285 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025WorsenedAnnual report

    「Net gain (loss) on equity securities was a ¥3,107 million loss in the current fiscal year, compared with a ¥24,675 million gain in the previous fiscal year.」

    Gain (loss) on equity securities turned from a ¥24,675 million gain in the previous fiscal year to a ¥3,107 million loss in the current fiscal year, depressing profit before income taxes.
  2. FY2025-H1WorsenedAnnual report

    「Total current-period gain (loss) on equity securities 14,838 △4,026」

    Gain (loss) on equity securities turned from a ¥14,838 million gain in the same period of the previous year to a ¥4,026 million loss in the current interim period. Lower valuation gains on investment securities and other factors contributed to a 7.7% year-on-year decline in interim profit before income taxes.
  3. FY2024Gains and losses on equity securities changed from a loss to a gainAnnual report

    「Net gain (loss) on equity securities was a ¥24,675 million gain in the current fiscal year, compared with a ¥662 million loss in the previous fiscal year.」

    Gain (loss) on equity securities turned from a ¥662 million loss in the previous fiscal year to a ¥24,675 million gain in the current fiscal year, contributing to increases in profit before income taxes and net income.
  4. FY2024-Q3Gains and losses on equity securities changed from a loss to a gainAnnual report

    「Total current-period gain (loss) on equity securities △3,432 15,730」

    Gain (loss) on equity securities turned from a ¥3,432 million loss in the same period of the previous year to a ¥15,730 million gain in the current period, while higher valuation gains on investment securities contributed to increases in profit before income taxes and net income.
  5. FY2024-Q2Continued increase in investment securities valuation gainsAnnual report

    「Quarterly profit before income taxes was ¥152,074 million, up 17.4% year on year, due mainly to higher valuation gains on investment securities and other factors. Quarterly net income attributable to the Company's shareholders was ¥113,560 million, up 19.3% year on year.」

    Higher valuation gains on investment securities contributed to increases in quarterly profit before income taxes and quarterly net income attributable to the Company's shareholders.
  6. FY2024-Q1Gains and losses on equity securities changed from a loss to a gainAnnual report

    「Consolidated net sales for the cumulative first quarter of the current fiscal year increased mainly in the Medical Systems, Bio CDMO and Imaging businesses, reaching ¥660,759 million, up 5.6% year on year. Operating income was ¥52,217 million, up 5.4% year on year. Quarterly profit before income taxes was ¥69,297 million, up 25.5% year on year, due mainly to higher valuation gains on investment securities and other factors, while quarterly net income attributable to the Company's shareholders was ¥54,412 million, up 31.5% year on year.」

    Quarterly profit before income taxes and quarterly net income attributable to the Company's shareholders increased year on year due mainly to higher valuation gains on investment securities and other factors. Gain (loss) on equity securities also turned from a ¥759 million loss in the same period of the previous year to a ¥11,212 million gain.
  7. FY2023WorsenedAnnual report

    「Total current-period gain (loss) on equity securities 4,453 △662」

    Gain (loss) on equity securities turned from a ¥4,453 million gain in the previous fiscal year to a ¥662 million loss in the current fiscal year, with valuation gains and losses becoming a factor depressing profit before income taxes.
  8. FY2023-Q3WorsenedAnnual report

    「Quarterly profit before income taxes was ¥204,787 million, down 1.2% year on year, due mainly to lower valuation gains on investment securities and other factors. Quarterly net income attributable to the Company's shareholders was ¥153,735 million, down 2.1% year on year.」

    Quarterly profit before income taxes and quarterly net income attributable to the Company's shareholders declined year on year due mainly to lower valuation gains on investment securities and other factors.
  9. FY2023-Q2WorsenedAnnual report

    「Quarterly profit before income taxes was ¥129,534 million, down 0.3% year on year, due mainly to lower valuation gains on investment securities and other factors. Quarterly net income attributable to the Company's shareholders was ¥95,163 million, down 1.1% year on year.」

    Quarterly profit before income taxes and quarterly net income attributable to the Company's shareholders declined year on year due mainly to lower valuation gains on investment securities and other factors.
  10. FY2023-Q1WorsenedAnnual report

    「Total current-period gain (loss) on equity securities 14,836 △759」

    Gain (loss) on equity securities turned from a ¥14,836 million gain in the same period of the previous year to a ¥759 million loss in the current period, becoming a factor behind the decline in quarterly profit before income taxes.
  11. FY2022WorsenedAnnual report

    「Non-operating income and expenses decreased by ¥39,653 million from ¥70,397 million of non-operating income in the previous fiscal year to ¥30,744 million of non-operating income. Gain (loss) on equity securities declined from ¥48,778 million in the previous fiscal year to ¥4,453 million in the current fiscal year.」

    The profit contribution from gain (loss) on equity securities declined substantially from the previous fiscal year, and non-operating income also decreased from ¥70,397 million to ¥30,744 million.
  12. FY2022-Q3Gain (loss) on equity securities: lower profit and continued third-quarter lossAnnual report

    「Total current-period gain (loss) on equity securities 39,770 5,874」

    Gain (loss) on equity securities declined from a ¥39,770 million gain in the same period of the previous year to a ¥5,874 million gain in the current period. The third quarter alone recorded an ¥8,007 million loss, as lower valuation gains and recognition of losses continued.
  13. FY2022-Q2Gain (loss) on equity securities: lower valuation gains and quarterly lossAnnual report

    「Total current-period gain (loss) on equity securities 31,225 13,881」

    Cumulative second-quarter gain (loss) on equity securities declined from a ¥31,225 million gain in the same period of the previous year to a ¥13,881 million gain, while the second quarter alone recorded a ¥955 million loss.
  14. FY2022-Q1Updated equity securities valuation gainsAnnual report

    「Quarterly profit before income taxes was ¥77,784 million, up 84.3% year on year, due mainly to the recognition of valuation gains on equity securities and other factors. Quarterly net income attributable to the Company's shareholders was ¥57,307 million, up 108.4% year on year.」

    The recognition of valuation gains on equity securities continued, with quarterly profit before income taxes up 84.3% year on year and quarterly net income attributable to the Company's shareholders up 108.4%.
  15. FY2021Gain (loss) on equity securities turned profitableAnnual report

    「Non-operating income and expenses amounted to ¥70,397 million of non-operating income, compared with ¥13,499 million of non-operating expenses in the previous fiscal year.」

    Gain (loss) on equity securities caused non-operating results to turn from an expense of ¥13,499 million in the previous fiscal year to income of ¥70,397 million in the current fiscal year, contributing to increases in profit before income taxes and net income.
  16. FY2021-Q3Continued disclosure of higher equity securities valuation gainsAnnual report

    「Total current-period gain (loss) on equity securities 1,990 39,770」

    Gain (loss) on equity securities increased from a ¥1,990 million gain in the same period of the previous year to a ¥39,770 million gain for the cumulative third quarter, contributing to an increase in quarterly profit before income taxes.
  17. FY2021-Q2Equity securities valuation gains increased significantly from a loss in the same period of the previous yearAnnual report

    「Total current-period gain (loss) on equity securities △677 31,225」

    Gain (loss) on equity securities improved from a ¥677 million loss in the same period of the previous year to a ¥31,225 million gain for the cumulative second quarter, contributing to an increase in quarterly profit before income taxes.
  18. FY2021-Q1Change to valuation gains on equity securitiesAnnual report

    「Income before income taxes was ¥42,199 million, up 59.9% year on year, due to the recognition of valuation gains on equity securities and other factors. Net income attributable to the company’s shareholders was ¥27,501 million, up 87.6%.」

    The company changed from recognizing valuation losses on equity securities in the first quarter of the previous fiscal year to recognizing valuation gains in the current quarter, resulting in increases in income before income taxes and net income attributable to the company’s shareholders.
  19. FY2020WorsenedAnnual report

    「Due to the recognition of valuation losses on equity securities and other factors, non-operating income of ¥2,935 million in the previous fiscal year decreased by ¥16,434 million, resulting in non-operating expenses of ¥13,499 million.」

    Gains and losses on equity securities changed from non-operating income in the previous fiscal year to non-operating expenses in the current fiscal year, becoming a factor in the decline in income before income taxes.
  20. FY2020-Q3Gains and losses on equity securities changed from a loss to a gainAnnual report

    「Total gains (losses) on equity securities for the period △5,437 1,990」

    Gains and losses on equity securities changed from a loss of ¥5,437 million in the same period of the previous year to a gain of ¥1,990 million in the current period. Income before income taxes rose 7.7% year on year, while net income attributable to the company’s shareholders rose 19.4%.
  21. FY2020-Q2WorsenedAnnual report

    「Total gains (losses) on equity securities for the period 8,788 △677」

    Gains and losses on equity securities changed from a gain of ¥8,788 million in the same period of the previous year to a loss of ¥677 million in the current period. Income before income taxes of ¥97,532 million and net income attributable to the company’s shareholders of ¥61,145 million fell 1.3% and 6.6%, respectively, year on year.
  22. FY2020-Q1First statedAnnual report

    「Income before income taxes was ¥26,392 million, down 42.4% year on year, due to the recognition of valuation losses on equity securities and other factors. Net income attributable to the company’s shareholders was ¥14,662 million, down 48.2%.」

    The company disclosed year-on-year declines in income before income taxes and net income attributable to the company’s shareholders due to the recognition of valuation losses on equity securities and other factors.
Moved together

"Policy Changes in Europe, the United States and Emerging Markets and Geopolitical Risks" moved the same way as this thread, in the same document, in 5 of its 22 moves.

533222★123456
  1. ★This thread
  2. 1Policy Changes in Europe, the United States and Emerging Markets and Geopolitical Risks5×
  3. 2Increasing Magnetic Tape Capacity and Expanding Long-Term Storage Services3×
  4. 3Business Expansion into Touch Panels, Environmental Energy and Other Areas3×
  5. 4Expansion into a Total Healthcare Company2×
  6. 5Document growth centered on global services and production services2×
  7. 6Declining Imaging Solutions sales and profit, and the rollout of high-value-added products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for FUJIFILM Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in Profit Before Tax and Net Income Due to Impairment Losses on Equity Securities | FUJIFILM Holdings Corporation (4901) | Komori